HEALTHFUTURES, LLC

View full entity profile (contributions, contracts, SEC) →

Lobbying Income

$1.1M

Filings

Unique Clients

Active Period

2008–2011

Lobbying Income by Year

Registrant-reported income from clients on LDA filings

Year	Lobbying Income	Filings	Clients
2011	$180,000	10	5
2010	$510,000	20	5
2009	$390,000	28	7
2008	$50,000	16	4

Top Clients

Largest clients by registrant-reported income

Client	Reported Income	Filings	Period
LIFE TECHNOLOGIES	$380,000	10	2009–2011
TETHYS BIOSCIENCE	$330,000	14	2008–2011
ASSOCIATION FOR MOLECULAR PATHOLOGY	$280,000	15	2008–2011
TESSARAE	$70,000	7	2008–2009
NAVIGENICS, INC.	$70,000	14	2008–2011
MEDCO HEALTH SOLUTIONS INC	—	3	2009
INTERLEUKIN GENETICS, INC.	—	11	2009–2011

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
SENATE	47
HOUSE OF REPRESENTATIVES	44
Health & Human Services, Dept of (HHS)	32
Food & Drug Administration (FDA)	29
Centers For Disease Control & Prevention (CDC)	8
Natl Institute of Standards & Technology (NIST)	8
Natl Institutes of Health (NIH)	7
Centers For Medicare and Medicaid Services (CMS)	5
Labor, Dept of (DOL)	3
Treasury, Dept of	3
Natl Science Foundation (NSF)	2
State, Dept of (DOS)	2

Top Issues Lobbied

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	50
Medical/Disease Research/Clinical Labs	Medical/Disease Research/Clinical Labs	37
Consumer Issues/Safety/Products	Consumer Issues/Safety/Products	8
Agriculture	Agriculture	7
Insurance	Insurance	6
Science/Technology	Science/Technology	5
Food Industry (safety, labeling, etc.)	Food Industry (safety, labeling, etc.)	4
Medicare/Medicaid	Medicare/Medicaid	4
Civil Rights/Civil Liberties	Civil Rights/Civil Liberties	1
Homeland Security	Homeland Security	1

Bills Explicitly Cited (25)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 5116110th Congress

To extend the temporary suspension of duty on certain nickel-metal hydride storage batteries designed for use in hybrid vehicles.

2010 · fourth_quarter · Client: ASSOCIATION FOR MOLECULAR PATHOLOGY

Open original LDA filing ↗

Cited source text and reported amounts

Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act

Client expense: — · Firm income: $30,000

Matched citations: HR 5116

H.R. 5440111th Congress

Genomics and Personalized Medicine Act of 2010

2010 · fourth_quarter · Client: ASSOCIATION FOR MOLECULAR PATHOLOGY

Open original LDA filing ↗

Cited source text and reported amounts

Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act

Client expense: — · Firm income: $30,000

Matched citations: HR 5440

H.R. 5440111th Congress

Genomics and Personalized Medicine Act of 2010

2010 · fourth_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science No Bill#, BETTER Patient Care Act

Client expense: — · Firm income: $50,000

Matched citations: HR 5440

H.R. 5440111th Congress

Genomics and Personalized Medicine Act of 2010

2010 · fourth_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza No Bill#, BETTER Patient Care Act

Client expense: — · Firm income: $50,000

Matched citations: HR 5440

Show 21 more cited filings

H.R. 805111th Congress

Strengthening America's Public Health System Act

2010 · fourth_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science No Bill#, BETTER Patient Care Act

Client expense: — · Firm income: $50,000

Matched citations: HR 805

H.R. 805111th Congress

Strengthening America's Public Health System Act

2010 · fourth_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza No Bill#, BETTER Patient Care Act

Client expense: — · Firm income: $50,000

Matched citations: HR 805

H.R. 5116110th Congress

To extend the temporary suspension of duty on certain nickel-metal hydride storage batteries designed for use in hybrid vehicles.

2010 · third_quarter · Client: ASSOCIATION FOR MOLECULAR PATHOLOGY

Open original LDA filing ↗

Cited source text and reported amounts

Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act

Client expense: — · Firm income: $30,000

Matched citations: HR 5116

H.R. 5440111th Congress

Genomics and Personalized Medicine Act of 2010

2010 · third_quarter · Client: ASSOCIATION FOR MOLECULAR PATHOLOGY

Open original LDA filing ↗

Cited source text and reported amounts

Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act

Client expense: — · Firm income: $30,000

Matched citations: HR 5440

H.R. 5440111th Congress

Genomics and Personalized Medicine Act of 2010

2010 · third_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science

Client expense: — · Firm income: $50,000

Matched citations: HR 5440

H.R. 5440111th Congress

Genomics and Personalized Medicine Act of 2010

2010 · third_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza

Client expense: — · Firm income: $50,000

Matched citations: HR 5440

H.R. 805111th Congress

Strengthening America's Public Health System Act

2010 · third_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science

Client expense: — · Firm income: $50,000

Matched citations: HR 805

H.R. 805111th Congress

Strengthening America's Public Health System Act

2010 · third_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza

Client expense: — · Firm income: $50,000

Matched citations: HR 805

H.R. 5116110th Congress

To extend the temporary suspension of duty on certain nickel-metal hydride storage batteries designed for use in hybrid vehicles.

2010 · second_quarter · Client: ASSOCIATION FOR MOLECULAR PATHOLOGY

Open original LDA filing ↗

Cited source text and reported amounts

Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act

Client expense: — · Firm income: $30,000

Matched citations: HR 5116

H.R. 5440111th Congress

Genomics and Personalized Medicine Act of 2010

2010 · second_quarter · Client: ASSOCIATION FOR MOLECULAR PATHOLOGY

Open original LDA filing ↗

Cited source text and reported amounts

Issues impacting the legislative and regulatory oversight of genetic testing, reimbursement of diagnostics, DNA patents, workforce issues, standards development for diagnostics HR 5440,Genomics and Personalized Medicine Act; No bill #, Genomic Research and Accessibility Act HR 5116, America Competes Reauthorization Act, genetic testing No bill #, BETTER Patient Care Act

Client expense: — · Firm income: $30,000

Matched citations: HR 5440

H.R. 5116110th Congress

To extend the temporary suspension of duty on certain nickel-metal hydride storage batteries designed for use in hybrid vehicles.

2010 · second_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza HR 5116, America Competes Reauthorization Act, bioscience research program at NIST S. 1649, Weapons of Mass Destruction Prevention and Preparedness Act, pandemic influenza

Client expense: — · Firm income: $50,000

Matched citations: HR 5116

H.R. 5440111th Congress

Genomics and Personalized Medicine Act of 2010

2010 · second_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza HR 5116, America Competes Reauthorization Act, bioscience research program at NIST S. 1649, Weapons of Mass Destruction Prevention and Preparedness Act, pandemic influenza

Client expense: — · Firm income: $50,000

Matched citations: HR 5440

H.R. 5440111th Congress

Genomics and Personalized Medicine Act of 2010

2010 · second_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science

Client expense: — · Firm income: $50,000

Matched citations: HR 5440

H.R. 805111th Congress

Strengthening America's Public Health System Act

2010 · second_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza HR 5116, America Competes Reauthorization Act, bioscience research program at NIST S. 1649, Weapons of Mass Destruction Prevention and Preparedness Act, pandemic influenza

Client expense: — · Firm income: $50,000

Matched citations: HR 805

H.R. 805111th Congress

Strengthening America's Public Health System Act

2010 · second_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science

Client expense: — · Firm income: $50,000

Matched citations: HR 805

S. 1649111th Congress

WMD Prevention and Preparedness Act of 2009

2010 · second_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza HR 5116, America Competes Reauthorization Act, bioscience research program at NIST S. 1649, Weapons of Mass Destruction Prevention and Preparedness Act, pandemic influenza

Client expense: — · Firm income: $50,000

Matched citations: S. 1649

H.R. 3590110th Congress

American Middle Class Tax (AMT) Relief Act of 2007

2010 · first_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

No Bill#, Genomics and Personalized Medicine Act, Personalized medicine HR 3590, Patient Protection and Affordable Care Act, Pandemic influenza HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science

Client expense: — · Firm income: $50,000

Matched citations: HR 3590

H.R. 805111th Congress

Strengthening America's Public Health System Act

2010 · first_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

No Bill#, Genomics and Personalized Medicine Act, Personalized medicine HR 3590, Patient Protection and Affordable Care Act, Pandemic influenza HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science

Client expense: — · Firm income: $50,000

Matched citations: HR 805

H.R. 805111th Congress

Strengthening America's Public Health System Act

2010 · first_quarter · Client: LIFE TECHNOLOGIES

Open original LDA filing ↗

Cited source text and reported amounts

No Bill#, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza

Client expense: — · Firm income: $50,000

Matched citations: HR 805

H.R. 3962110th Congress

Superfund Polluter Pays Act

2010 · first_quarter · Client: TETHYS BIOSCIENCE

Open original LDA filing ↗

Cited source text and reported amounts

Issues relating to health care policy and the prevention of diabetes No bill #, America's Healthy Future Act, prevention of Type 2 diabetes HR 3200, America's Affordable Health Choices Act H.R. 3962, Affordable Helath Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Affordability Reconciliation Act of 2010 Regulation of laboratory developed tests.

Client expense: — · Firm income: $30,000

Matched citations: H.R. 3962

H.R. 3200111th Congress

America's Affordable Health Choices Act of 2009

2010 · first_quarter · Client: TETHYS BIOSCIENCE

Open original LDA filing ↗

Cited source text and reported amounts

Issues relating to health care policy and the prevention of diabetes No bill #, America's Healthy Future Act, prevention of Type 2 diabetes HR 3200, America's Affordable Health Choices Act H.R. 3962, Affordable Helath Care for America Act; H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Affordability Reconciliation Act of 2010 Regulation of laboratory developed tests.

Client expense: — · Firm income: $30,000

Matched citations: HR 3200

Source: Senate LDA

HEALTHFUTURES, LLC — Lobbying Disclosure | Poliscope